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Abstract
Introduction: Severe acute respiratory syndrome coron-
avirus 2 (SARS-CoV-2), famously known as COVID-19, has
quickly become a global pandemic. Chest X-ray (CXR) imag-
ing has proven reliable, fast, and cost-effective for identify-
ing COVID-19 infections, which presents with atypical uni-
lateral patchy infiltration in the lungs like typical pneumonia.
We employed the deep convolutional neural network (DCNN)
ResNet-34 to detect and classify CXR images from patients
with COVID-19, other viral pneumonias, and normal controls.
Methods: We created a single database, containing 781
source CXR images for COVID-19 (n=240), other viral pneu-
monias (n=274), and normal controls (n=267) from four
different international sub-databases: the Società Italiana
di Radiologia Medica e Interventistica (SIRM), the GitHub
Database, the Radiology Society of North America (RSNA),
and the Kaggle Chest X-Ray Database. Images were re-
sized, normalized without any augmentation, and arranged in
m batches of 16 images before supervised training, testing,
and cross-validation of the DCNN classifier.
Results: The ResNet-34 had a diagnostic accuracy as of the
receiver operating characteristic (ROC) curves of the true-
positive rate versus the false-positive rate with the area un-
der the curve (AUC) of 1.00, 0.99, and 0.99, for COVID-19,
other viral pneumonia, and normal control CXR images, re-
spectively. This accuracy implied identical high sensitivity
and specificity values of 100%, 99%, and 99% for the three
groups, respectively. ResNet-34 achieved identical sensitiv-
ity and specificity of 100%, 99.6%, and 98.9% for classifying
CXR images of the three groups, with an overall accuracy of
99.5% for the testing subset for diagnosis/prognosis.
Conclusion: Based on this high classification precision, we
believe that the output activation map of the final layer of the
ResNet-34 is a powerful tool for the accurate diagnosis of
COVID-19 infection from CXR images.
Introduction
Since December 2019, the severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2), famously known
as COVID-19, has quickly become a global pan-
demic. In fact, as of October 14, 2021, reports to
the World Health Organization (WHO) have amounted
to 239,007,759 confirmed cases, including 4,871,841
deaths.[1] The pandemic continues to have disastrous
effects on health, industry, and social life worldwide.
The disease’s long-term symptoms range from flu-like
signs to severe respiratory distress syndrome. Patients
exhibit evident anomalies (i.e., opacities and lung con-
solidations) in chest X-ray (CXR) images.[2, 3] Rapid
and accurate detection of COVID-19 is crucial to con-
trol outbreaks in the community and hospitals.[4] Re-
verse transcriptase quantitative polymerase chain reac-
tion (RT-qPCR) testing, which can detect SARS-CoV-
2 RNA in different types of clinical specimens, is the
primary technique used for diagnosis. Nevertheless,
RT-qPCR testing is time-consuming, complex, and its
sensitivity is highly variable with a high probability of
false detection.[2, 5]
Medical imaging techniques such as CXR and com-
puted tomography (CT) have proven reliable, fast, and
cost-effective for detecting lung diseases and identify-
ing COVID-19 infections compared to RT-qPCR.[6] Al-
ULJRI | https://ir.library.louisville.edu/jri/vol5/iss1/34 1
ULJRI DCNNs for Accurate Diagnosis of COVID-19
Table 1. Examples of machine learning and artificial intelligence techniques in different medical fields
Reference Domain Technique Technology Topic
[10] Radiology Ultrasound Regression Breast cancer
[11] Radiology CT ML Lungs
[12] Radiology MRI ML Brain
[13] Radiology X-ray ML Chest
[14] Hematology Laboratory ML Biological hematology
[15] Hematology HSCT ML aGVHD
[16] Hematology Flow cytometry AI Leukemia
[17] Hematology Flow cytometry AI Leukemia
[18] Hematology Cytometry AI AML
[19] Hematology Laboratory DM PV
Abbreviations: aGVHD, acute graft-versus-host disease; AI, artificial intelligence;
AML, acute myeloid leukemia; CT, computed tomography; DM, data mining; HSCT,
hematopoietic stem cell transplantation; MRI, magnetic resonance imaging; PV, Poly-
chthemia Vera.
though CXR images do not show any irregularities at
the beginning of infection, as COVID-19 proceeds, it
slowly presents with atypical unilateral patchy infiltra-
tion in the lungs, which exhibit similarities to the char-
acteristics of other pneumonias.[7] Computer vision al-
gorithms have shown high performance in object de-
tection, image classification, and indexing for retrieval
and annotation at a large scale.[3] Of these, deep convo-
lutional neural networks (DCNN) with transfer learn-
ing have distinguished themselves in many computer-
vision tasks, such as image classification, especially in
the field of radiology for computer-aided diagnosis of
chronic lung diseases from CT Hounsfield unit values
or texture features.[3, 8, 9]
Transfer learning is a supervised machine learning
technique, which reuses parts of a previously trained
model in a specific field for another task in a new
model, with the advantages of using less training data,
better generalization, and affordable deep learning.[10-
15] Examples of the machine learning and artificial in-
telligence techniques already being tested or applied in
various medical fields are summarized in Table 1.[10-
19] Applying transfer learning to a pre-trained residual
neural network (ResNet) has been found very useful
as a starting point for training a new DCNN for image
recognition by modifying the activation function Soft-
max and the classification layer. Using the pre-trained
weights accelerates the training phase, employing only
the available small medical datasets, which avoids los-
ing a tremendous amount of time for training by large
datasets if one develops a new DCNN from scratch.[20]
The objective of the present study was to employ the
DCNN ResNet-34 for the detection and classification
(diagnosis/prognosis) of CXR images from patients
with COVID-19, other viral pneumonias, and normal
controls.[21]
Methods
Study population database and sample size
We calculated the sample size using STATA statisti-
cal software version 9 (StataCorp LLC, College Station,
TX, USA). The diagnosis of COVID-19 by the RT-qPCR
technique was considered the gold standard. We aimed
to achieve a confidence level of 99% and a margin of
error of 1% for the proposed DCNN model; hence,
the sample size should include at least 722 CXR im-
ages. Thus, we created a single database containing 781
source CXR images for COVID-19 (n=240), other viral
pneumonias (n=274), and normal controls (n=267) from
four different international sub-databases to train, val-
idate, and test the DCNN diagnosis/prognosis model.
These four databases were the following: the Società
Italiana di Radiologia Medica e Interventistica (SIRM)
COVID-19 Database, reporting 384 COVID-19 positive
CXR images [22]; the GitHub Database by Cohen et
al., containing 319 CXR images of COVID-19, severe
acute respiratory syndrome, Middle East respiratory
syndrome, and acute respiratory distress syndrome
[23]; the Radiology Society of North America (RSNA)
Pneumonia-Detection-Challenge Database, comprising
108,948 frontal-view CXR images of 32,717 unique pa-
tients for classification and localization of common tho-
rax diseases using a DCNN [24]; and finally, the Kaggle
Chest X-Ray Database, containing 5,247 CXR images of
normal controls and viral and bacterial pneumonia pa-
tients.[25]
Deep convolutional neural network model selection
A supervised pre-trained ResNet-34, a benchmarked
DCNN model with an error rate as low as 3.6%,
was trained, validated, and tested to detect, identify,
and classify our database of 781 CXR images.[21] We
trained the multilayer feed-forward ResNet-34 model
with backpropagation of errors using the Adam op-
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timization algorithm, with a learning rate of α=10-3
and a batch size of 16 random CXR images (i.e., of
COVID-19, other viral pneumonias, or normal con-
trols). The ResNet-34 structure has a moderate compu-
tational complexity, with 26.70 and 8.58 top-1 and top-5
errors, respectively.[26] Then, we evaluated the model
using the PyTorch Library of the Anaconda Package
(2021 Anaconda Inc., New York, USA) running on a
MacBook Pro (Intel i5-core @ 2.7 GHz processor and 16
GB RAM) under Mojave 10.14.6.[26]
Before applying the database of random inputs, CXR
images were all pre-processed—i.e., resized to 224 ×
224 to match input requirements and normalized, with-
out any image augmentation, according to standards
of the ResNet-34—and were arranged in m batches of
16 images. That is, we randomly divided the 781 CXR
images into 49 batches of 16 images each; we carried
out training out using 29 image batches (60%), valida-
tion using ten batches (20%), and testing for diagnosis
using the remaining ten batches (20%). As we passed
CXR image batches through the ResNet-34 for train-
ing, batch normalization in between skips double- or
triple-layers containing nonlinearities for image classi-
fication.[20]
To localize and highlight a critical region of interest
(ROI) for a particular category within an input CXR
image, we employed the Gradient-Weighted Class Ac-
tivation Mapping (Grad-CAM) method to explain the
DCNN prediction visually. It uses the gradient infor-
mation of a target class flowing back into the last con-
volutional layer to generate visual explanations from
the DCNN model. It generates a class activation map
from a residual block of the DCNN model (Figures 1A
and 1B), where it feeds the global average pooled con-
volutional feature maps into the fully connected final
output layer, which is defined as follows:[20]
y = Fk(x, wck) + x (Eq. 1)
where x and y are the input and output vectors of
the building block, Fk(x, wck) is the residual mapping,
Fk ∈ Ru×v represents the global average pooling that
spatially averages the kth feature map of width u and
height v produced from the last convolution layer of the
DCNN, and wck is the weight connecting the kth feature
map to an output node corresponding to class c. For
the residual block considered in Figure 1B, F is given
by:
F = w2ReLU(w1x) + x (Eq. 2)
where ReLU(.) is the rectified linear unit and is given
by:
ReLU(x) = max(0, x) (Eq. 3)
The prediction score (i.e., the input to the activation
function Softmax) at the output layer, Sc, can be ex-
pressed as a weighted sum of the global average pool-
ing concerning the kth feature map given by:
Sc = ΣkwckF
k
= ΣkwckΣx,y fk(x, y)
= Σx,yΣkwck fk(x, y)
(Eq. 4)
where fk(x, y) denotes the spatial element (x, y) activa-
tion in the kth feature map. The class activation map
of class c, Mc ∈ Ru×v, is defined as a weighted sum of
activation at spatial element (x,y) from all feature maps.
Mc(x, y) = Σkwck fk(x, y) (Eq. 5)
The definition of the Grad-CAM for a class c is the
weighted sum of all feature maps resulting from the
last convolution layer in a DCNN. We applied the
ReLU function (Eq. 3) to remove the potential influence
of negative weights on the class of interest, considering
that the spatial elements in the feature maps associated
with the negative weights were likely to belong to other
categories in the image.
Grad Mc(x, y) = ReLU(Σkαck fk(x, y)) (Eq. 6)
where αck is the weight obtained by computing the gra-





Figure 1C shows the DCNN model (ResNet-34) block
diagram for diagnosis/prognosis, which consists of a
three-step pipeline for 1) detecting random CXR im-
ages, where the first layers detect edges and shapes
while the last layers work on the details; 2) identifying
all suspicious patchy infiltrates in the CXR image of the
lung; and 3) classifying (i.e., diagnosing) of COVID-19,
other viral pneumonias, and normal controls.
The performance of the ResNet-34 was monitored
graphically, including the training loss, validation loss,
and error rate along epochs. We assessed the accu-
racy of classification (i.e., diagnosis) by the receiver
operating characteristic (ROC) curve, the area under
the curve (AUC), sensitivity, and specificity analysis,
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Table 2. Accuracy and error rate of k-fold cross-validation tests.
K-fold Accuracy (%) Error rate
1 99.14 8.61 × 10-3
2 99.31 6.89 × 10-3
3 99.48 5.16 × 10-3
4 98.62 13.77 × 10-3
5 98.97 10.33 × 10-3
Average result 99.11 8.95 × 10-3
a) b)
Figure 3. Chi square of ResNet-34 classification results (diagnosis/prognosis) of a) COVID-19 versus normal control chest X-ray images and b)
other viral pneumonia versus normal control chest X-ray images.
as well as a chi square for actual versus predicted
values of COVID-19 versus normal control CXR im-
ages, and another for other viral pneumonia, versus
normal control CXR images. We showed samples of
grayscale X-ray input images and output colored acti-
vation map grids for COVID-19, other viral pneumo-
nias, and normal controls. Finally, we carried out k-fold
cross-validation tests to classify all 781 source CXR im-
ages from COVID-19 (n=240), other viral pneumonias
(n=274), and normal controls (n=267), divided equally
randomly among each one- to five-fold, respectively.
Results
The performance of the ResNet-34 model, where the
training and validation loss of random subsets of CXR
images and the error rate with the number of epochs
converge at the end of the training phase. (Figures 2A–
C) An epoch is a measure of the cycles through the full
training process using image batches once to update
the ResNet-34 weights. We found that ten epochs were
sufficient to avoid both under- and over-fitting, reflect-
ing the high precision of testing in the subset of random
CXR images used for the diagnosis/prognosis. Fun-
damental measures of the diagnostic accuracy of the
ResNet-34 model, as of ROC curves of the true positive
rate versus the false positive rate for COVID-19, other
viral pneumonia, and normal control CXR images, are
shown in Figures 2D–F. AUC values for COVID-19,
other viral pneumonias, and normal controls were 1.00,
0.99, and 0.99, which signify a perfect accuracy in the
diagnosis and identical sensitivity and specificity val-
ues of 100, 99, and 99% for the three groups, respec-
tively, by three-fold cross-validation test, as shown in
Table 2. In general, the ResNet-34 achieved a high av-
erage accuracy of 99.11% and a low error rate of 8.95 ×
10-3 in classifying all source CXR images.
Moreover, the chi squares of Figure 3 show that the
ResNet-34 had identical sensitivity and specificity of
100, 99.6, and 98.9% in classifying all source CXR im-
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ages of COVID-19, other viral pneumonias, and nor-
mal controls, respectively. The overall accuracy of the
ResNet-34 for testing the subset of random CXR images
used for the diagnosis/prognosis was as high as 99.5%,
indicating an error rate as low as 0.5%.
Figures 4A–C show an example of the input CXR
grayscale images batch for COVID-19, other viral pneu-
monias, and normal controls. Figures 4D–F also
show an example of the colored activation map of the
ResNet-34 final output layer for the three different sub-
sets. The activation map is a proper visual diagnostic
representation, highlighting the morphological anoma-
lies of a CXR image that contribute most to the ResNet-
34 classification process.
Discussion
X-ray imaging for computer-aided medical detection,
classification, and diagnosis of many diseases is an ac-
tive field of research. It is accessible and can be per-
formed at a low cost using portable units in clinics or
homes.[27, 28] Digital image processing effectively vi-
sualizes and extracts essential details, with many avail-
able techniques for enhancing the quality of a standard
X-ray image before the diagnosis. Elsharkawy et al.
have recently proposed a pre-processing technique for
correcting CXR images for non-uniformity of illumina-
tion and delimiting the boundaries of lungs using an
automated segmentation routine or manual delineation
by radiologists.[28] The technique uses estimates of the
Markov–Gibbs random field energy at several radii to
compute the cumulative distribution function describ-
ing the lung nodules and determine the severity of in-
fection using a neural-network fusion and diagnostic
system. Vieira et al. have also proposed image resizing
using the maximum window function, which preserves
anatomical structures of the chest, to increase the clas-
sification rate regardless of the deep learning architec-
tures used.[29]
Radiologists rely on the appearance of CXR images
to identify any atypical unilateral patchy infiltration
in the lungs of COVID-19 patients, although there no
irregularities in the first grades of infection, and, if
present, they may be confused with pneumonia.[7]
Thus, to train a high-performance DCNN for diag-
nosis/prognosis of COVID-19 infection, using large
datasets for training is essential. However, large repos-
itories containing enough CXR images are not always
available. Thus, transfer learning is the base for ini-
tializing a DCNN model, fine-tuned using the avail-
able limited medical datasets with results that out-
perform fully trained models under particular condi-
tions.[20] The ResNet-34 model showed a very high
performance, as of the convergence of the training
loss, validation loss, and the error rate along with
the training phase with the number of epochs to zero
(Figures 2A–C). The distinctive nature of ResNet-34,
which builds on constructs from pyramidal cells in the
cerebral cortex using skip connections or shortcuts to
jump over some layers, permits the advantageous re-
duction of over-fitting and leads to faster optimization
of and better overall performance of the model. That is,
only ten epochs were required to attain a high precision
of testing and cross-validation of the subset of random
CXR images without under- or over-fitting (Table 2).
AUC analysis of ROC curves (Figure 2D–F) of true-
positive rate (i.e., sensitivity) versus false-positive rate
(i.e., 1–specificity) shows that points in the upper left
corner signify sensitivity and specificity as high as
100, 99, and 99% for COVID-19, other viral pneumo-
nias, and normal controls, respectively, by three-fold
cross-validation. Generally, ROC curves lie between
the lines connecting (0,0) to (0,1) and (0,1) to (1,1) ex-
tremes, where the area under the ROC curve is a sum-
mary measure that essentially averages the diagnostic
accuracy of model predictions. The RSNA and other
COVID-19 open access CXR image repositories have
formed the basis for many studies for detecting pneu-
monia and COVID-19.[7, 24] One of these is the recent
study by Zhang et al.[30] They have successfully em-
ployed a pre-trained 18-layer ResNet using ImageNet
weights for screening CXR images to detect, identify,
and classify 106 COVID-19 patients and 107 normal
controls without any fine-tuning. They showed that
the ResNet achieved an AUC of 83.61% and sensitiv-
ity of 71.70%, which they maintain is comparable to the
radiologists’ performance reported in the literature.
The ResNet-34 had identical sensitivity and specificity
of 100, 99.6, and 98.9% in classifying all source CXR im-
ages, without any image augmentation, of COVID-19,
other viral pneumonias, and normal controls, respec-
tively (Figure 3). The overall accuracy of the ResNet-34
for testing the subset of random CXR images used for
diagnosis/prognosis was as high as 99.5%. The error
rate of 0.5% in the testing phase is much lower than
the 3.6% showed for the benchmarked ResNet-34.[21]
Our group has lately shown similar high-performance
results for estimating bone mineral density from DXA-
DICOM images with an accuracy of 100% for the train-
ing, cross-validation, and testing phases of an ANN,
yet with much-elaborated image processing for fea-
ture extraction using both histogram and binary algo-
rithms.[27] The highest accuracy yielded by the auto-
mated framework recently proposed by Akram et al. for
the rapid diagnosis of COVID-19 from a limited num-
ber of CT images of patients from a public domain web-
site, with augmented feature classification using the
Naive Bayes classifier, was only 92.6%.[31]
Wang and Wong have recently introduced COVID-
Net, an open-source DCNN design tailored for detect-
ing COVID-19, pneumonia, and normal controls from
CXR images, which is available to the public.[32] To
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assist radiologists to automatically diagnose COVID-
19 in X-ray images, Hemdan et al. trained and vali-
dated their COVIDX-Net using a small dataset, which
included only 25 COVID-19-positive patients.[33] The
COVIDX-Net included seven different architectures of
DCNN models, such as the modified Visual Geome-
try Group Network (VGG19) and the second version of
Google MobileNet, which classified the patients’ nor-
malized intensities of X-ray images as negative or pos-
itive COVID-19. The VGG19 and Dense Convolutional
Network (DenseNet) models showed a good and simi-
lar performance of automated COVID-19 classification
with f1-scores of 0.89 and 0.91 for normal controls and
COVID-19, respectively. The sensitivity of the COVID-
Net was 91, 94, and 95% for COVID-19, pneumonia pa-
tients, and normal controls, respectively, with an over-
all performance accuracy of 93.3%.
Distinguishing morphological anomalies in CXR im-
ages of COVID-19 patients from typical pneumonia
patients is not easy. We employed the Grad-CAM
method to localize and visualize an ROI within CXR
images, which consistently highlights a specific area
common in shape, pattern, or location among CXR
images within the same class but distinct or different
from images in other modality classes.[20] The activa-
tion map (Figures 4D–F) is thus a proper visual di-
agnostic representation, highlighting the morphologi-
cal anomalies of a CXR image that contribute the most
to the ResNet-34 classification process. Li et al. have
recently addressed this problem of automatically dis-
tinguishing between COVID-19 and typical pneumo-
nia using a U-Net pre-processor network for lung field
segmentation, followed by a 3D ResNet-50 using trans-
ferred ImageNet weights.[34] Their model attained an
accuracy of 87% using a dataset collected from 6 hos-
pitals. Furthermore, the DenseNet-169 CNN model,
tested to identify COVID-19 from CT slices without
and with segmentation, showed 79.5% and 83.3% ac-
curacy, respectively.[35] A model based on a combi-
nation of U-Net and 3D CNN has identified the pres-
ence of COVID-19 with a 90% accuracy using CT im-
ages.[36] An accuracy of 94% has also been achieved
with a ResNet-50-based CNN using transfer learning
weighted from the ImageNet.[37]
In conclusion, distinguishing morphological anoma-
lies in CXR images (i.e., opacities and lung consoli-
dations displayed as atypical unilateral patchy infil-
tration in the lungs) of COVID-19 patients from those
of other pneumonia patients is cumbersome. It usu-
ally requires a highly expert radiologist and typically
ends with ordering other expensive CT scans, which
burdens the national health systems of all countries
and delays the diagnosis of COVID-19 patients. In the
present study, we employed the ResNet-34 for the de-
tection and classification (diagnosis/prognosis) of CXR
images of COVID-19, other viral pneumonias, and nor-
mal controls from four international sub-databases: the
Società Italiana di Radiologia Medica e Interventistica
(SIRM), the GitHub database, the Radiology Society of
North America (RSNA), and the Kaggle chest X-ray
database. Images were resized, normalized without
any image augmentation, and arranged in m batches
of 16 images before supervised training and validation
of the DCNN classifier. The ResNet-34 model achieved
identical sensitivity and specificity of 100%, 99.6%, and
98.9% in classifying CXR images of COVID-19, other
viral pneumonias, and normal controls, respectively,
with an overall accuracy of 99.5% for the testing sub-
set for diagnosis/prognosis. Based on this high classi-
fication precision, we believe that the output activation
map of the final layer of the ResNet-34 is a powerful
tool for the accurate diagnosis of COVID-19 infection
from CXR images.
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